266 related articles for article (PubMed ID: 29209847)
1. Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score.
Rupa-Matysek J; Gil L; Kaźmierczak M; Barańska M; Komarnicki M
Med Oncol; 2017 Dec; 35(1):5. PubMed ID: 29209847
[TBL] [Abstract][Full Text] [Related]
2. Mean platelet volume as a predictive marker for venous thromboembolism and mortality in patients treated for diffuse large B-cell lymphoma.
Rupa-Matysek J; Gil L; Kroll-Balcerzak R; Barańska M; Komarnicki M
Hematol Oncol; 2017 Dec; 35(4):456-464. PubMed ID: 27377517
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of risk factors and assessment models for predicting venous thromboembolism in lung cancer patients.
Rupa-Matysek J; Lembicz M; Rogowska EK; Gil L; Komarnicki M; Batura-Gabryel H
Med Oncol; 2018 Apr; 35(5):63. PubMed ID: 29616356
[TBL] [Abstract][Full Text] [Related]
4. Performance of Khorana Risk Score for Prediction of Venous Thromboembolism in Patients With Hepatocellular Carcinoma.
Wang Y; Attar BM; Fuentes HE; Yu J; Zhang H; Tafur AJ
Clin Appl Thromb Hemost; 2018 Apr; 24(3):471-476. PubMed ID: 28288526
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the ThroLy score for the prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies in clinical practice.
Rupa-Matysek J; Brzeźniakiewicz-Janus K; Gil L; Krasiński Z; Komarnicki M
Cancer Med; 2018 Jul; 7(7):2868-2875. PubMed ID: 29761831
[TBL] [Abstract][Full Text] [Related]
6. Mean platelet volume as a predictive marker for venous thromboembolism in patients treated for Hodgkin lymphoma.
Rupa-Matysek J; Gil L; Barańska M; Dytfeld D; Komarnicki M
Oncotarget; 2018 Apr; 9(30):21190-21200. PubMed ID: 29765530
[TBL] [Abstract][Full Text] [Related]
7. Incidence of venous thromboembolism and predictive ability of age-adjusted international prognostic index for prediction of venous thromboembolism in Asian patients with diffuse large B-cell lymphoma.
Hantrakun N; Phinyo P; Tantiworawit A; Rattarittamrong E; Chai-Adisaksopha C; Rattanathammethee T; Hantrakool S; Piriyakhuntorn P; Punnachet T; Niprapan P; Norasetthada L
J Thromb Thrombolysis; 2024 Mar; 57(3):473-482. PubMed ID: 38091158
[TBL] [Abstract][Full Text] [Related]
8. Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer.
Mansfield AS; Tafur AJ; Wang CE; Kourelis TV; Wysokinska EM; Yang P
J Thromb Haemost; 2016 Sep; 14(9):1773-8. PubMed ID: 27273134
[TBL] [Abstract][Full Text] [Related]
9. Cross-sectional Study of Patients with Diffuse Large B-Cell Lymphoma: Assessing the Effect of Host Status, Tumor Burden, and Inflammatory Activity on Venous Thromboembolism.
Lim SH; Woo SY; Kim S; Ko YH; Kim WS; Kim SJ
Cancer Res Treat; 2016 Jan; 48(1):312-21. PubMed ID: 25761485
[TBL] [Abstract][Full Text] [Related]
10. Aggressive lymphoma subtype is a risk factor for venous thrombosis. Development of lymphoma - specific venous thrombosis prediction models.
Dharmavaram G; Cao S; Sundaram S; Ayyappan S; Boughan K; Gallogly M; Malek E; Metheny L; Tomlinson B; Otegbeye F; Lazarus HM; Cooper B; Fu P; de Lima M; Caimi PF
Am J Hematol; 2020 Aug; 95(8):918-926. PubMed ID: 32311162
[TBL] [Abstract][Full Text] [Related]
11. Venous Thromboembolism Is an Independent Predictor of Mortality Among Patients with Gastric Cancer.
Fuentes HE; Oramas DM; Paz LH; Wang Y; Andrade XA; Tafur AJ
J Gastrointest Cancer; 2018 Dec; 49(4):415-421. PubMed ID: 28634671
[TBL] [Abstract][Full Text] [Related]
12. Using the Khorana risk score to predict venous thromboembolism and overall survival in a cohort of Hispanic patients with solid malignancies.
Ramos-Esquivel A; Marenco-Flores A; Hernández-Romero G; Umaña-Mora C; Céspedes-Calvo A; Mora-Hidalgo R
Ecancermedicalscience; 2022; 16():1470. PubMed ID: 36819798
[TBL] [Abstract][Full Text] [Related]
13. Validation of the Khorana Venous Thromboembolism Risk Score in Japanese Cancer Patients.
Akasaka-Kihara F; Sueta D; Ishii M; Maki Y; Hirakawa K; Tabata N; Ito M; Yamanaga K; Fujisue K; Hoshiyama T; Hanatani S; Kanazawa H; Takashio S; Arima Y; Araki S; Usuku H; Nakamura T; Suzuki S; Yamamoto E; Soejima H; Kaikita K; Matsushita K; Matsuoka M; Usuku K; Tsujita K
JACC Asia; 2021 Sep; 1(2):259-270. PubMed ID: 36338156
[TBL] [Abstract][Full Text] [Related]
14. High plasma levels of soluble P-Selectin and Factor VIII predict venous thromboembolism in non-small cell lung cancer patients: The Thrombo-Nsclc risk score.
Castellón Rubio VE; Segura PP; Muñoz A; Farré AL; Ruiz LC; Lorente JA
Thromb Res; 2020 Dec; 196():349-354. PubMed ID: 32977135
[TBL] [Abstract][Full Text] [Related]
15. Incidence and risk factors for developing venous thromboembolism in Japanese with diffuse large b-cell lymphoma.
Yokoyama K; Murata M; Ikeda Y; Okamoto S
Thromb Res; 2012 Jul; 130(1):7-11. PubMed ID: 22000981
[TBL] [Abstract][Full Text] [Related]
16. Incidence of venous thromboembolism in patients with diffuse large B-cell lymphoma.
Borg IH; Bendtsen MD; Bøgsted M; Madsen J; Severinsen MT
Leuk Lymphoma; 2016 Dec; 57(12):2771-2776. PubMed ID: 27266904
[TBL] [Abstract][Full Text] [Related]
17. The Khorana Score in Predicting Venous Thromboembolism for Patients With Metastatic Urothelial Carcinoma and Variant Histology Treated With Chemotherapy.
Ramos JD; Casey MF; Bamias A; De Giorgi U; Bellmunt J; Harshman LC; Ladoire S; Wong YN; Alva AS; Rosenberg JE; Galsky MD; Yu EY;
Clin Appl Thromb Hemost; 2017 Oct; 23(7):755-760. PubMed ID: 27637910
[TBL] [Abstract][Full Text] [Related]
18. A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality.
Kuderer NM; Culakova E; Lyman GH; Francis C; Falanga A; Khorana AA
Oncologist; 2016 Jul; 21(7):861-7. PubMed ID: 27125754
[TBL] [Abstract][Full Text] [Related]
19. The Application of the ThroLy Risk Assessment Model to Predict Venous Thromboembolism in Patients with Diffuse Large B-Cell Lymphoma.
Abdel-Razeq H; Ma'koseh M; Mansour A; Bater R; Amarin R; Abufara A; Halahleh K; Manassra M; Alrwashdeh M; Almomani M; Zmaily M
Clin Appl Thromb Hemost; 2021; 27():10760296211045908. PubMed ID: 34590497
[TBL] [Abstract][Full Text] [Related]
20. Large retroperitoneal lymphadenopathy as a predictor of venous thromboembolism in patients with disseminated germ cell tumors treated with chemotherapy.
Srikanthan A; Tran B; Beausoleil M; Jewett MA; Hamilton RJ; Sturgeon JF; O'Malley M; Anson-Cartwright L; Chung PW; Warde PR; Winquist E; Moore MJ; Amir E; Bedard PL
J Clin Oncol; 2015 Feb; 33(6):582-7. PubMed ID: 25605848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
